✦ LIBER ✦

Phase 2a safety and immunogenicity testing of DNA and recombinant modified vaccinia ankara virus vaccines expressing virus-like particles

✍ Scribed by P Goepfert, M Elizaga, D Montefiori, J Hural, S DeRosa, G Tomaras…

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Correlation of immunogenicities and in v

✍ Linda S. Wyatt; Patricia L. Earl; Jennifer Vogt; Leigh Anne Eller; Dev Chandran; 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 952 KB

A prime/boost DNA/Modified vaccinia viru

✍ Connor Carson; Maria Antoniou; Maria Begoña Ruiz-Argüello; Antonio Alcami; Vasil 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 398 KB

Safety and immunogenicity of recombinant

✍ Walter Jaoko; Frederick N. Nakwagala; Omu Anzala; Gloria Omosa Manyonyi; Josephi 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 397 KB

Safety of DNA and modified vaccinia viru

✍ V.S. Moorthy; S. McConkey; M. Roberts; P. Gothard; N. Arulanantham; P. Degano; J 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 123 KB

Vaccination of infant macaques with a re

✍ Leon de Waal; Linda S Wyatt; Selma Yüksel; Geert van Amerongen; Bernard Moss; Hu 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 101 KB

Studies of a prophylactic HIV-1 vaccine

✍ Barry S. Peters; Walter Jaoko; Eftyhia Vardas; George Panayotakopoulos; Patricia 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 255 KB